Product Description
Overall, the global bone-anchored hearing aid market was valued at $440 million in 2021. This is expected to increase over the forecast period at a CAGR of 9.8% to reach $847 million.
The full report suite on the global market for bone-anchored hearing aids includes the analysis of the number of units sold, average selling price and market value. Overall, this global market research includes analysis spawning across more than 70 countries in the world.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL BONE-ANCHORED HEARING AID MARKET TRENDS
Bone-anchored hearing aids created a treatment option for a portion of the hearing-impaired population who could not be treated with standard hearing aids. Despite the market growth that bone-anchored hearing aids have enjoyed, this segment is still relatively far from saturation, which will drive rapid growth of this market.
GLOBAL BONE-ANCHORED HEARING AID MARKET SHARE INSIGHTS
Overall, within the global bone-anchored hearing aid market there are three dominant competitors: Cochlear, MED-EL, Demant Group.
In 2021, Cochlear was the leader of the global bone-anchored hearing aid market. Cochlear is one of the largest hearing implant manufacturers in the world, and it dominates both the cochlear implant and bone-anchored hearing system segments.
GLOBAL BONE-ANCHORED HEARING AID MARKET SEGMENTATION SUMMARY
- Bone-Anchored Hearing Aids (BAHA)
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2021 |
| Forecast Period | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE iDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
